Results 211 to 220 of about 24,009 (265)

Risk of interstitial lung disease in non-small cell lung cancer treated with EGFR-TKI: a real-world pharmacovigilance study. [PDF]

Front Pharmacol
Miao X, Liu Y, Li X, Zhao R.
europepmc   +1 more source

Observational suspected adverse drug reaction profiles of fluoro-pharmaceuticals and potential mimicry of per- and polyfluoroalkyl substances (PFAS) in the United Kingdom. [PDF]

PLoS One
Balasubramaniam B, Jones AM.
europepmc   +1 more source

Comparative in vitro assessment of CYP2C19 inhibition by ilaprazole and conventional proton pump inhibitors using a high throughput fluorometric assay. [PDF]

Sci Rep
Priyadharshini A, Vijayakumar TM, Damodharan N, Vasanth KM, Elaiyaraja A.   +4 more
europepmc   +1 more source

Concomitant Versus Tailored Therapy Based on Antibiotic Resistance Profiles for <i>Helicobacter pylori</i> Eradication: A Systematic Review and Meta-Analysis. [PDF]

JGH Open
Khalid A, Tabish S, Burhan M, Saad M, Gul I, Abid HMF, Hanif MS, Abdul Samad Z, Rasool A, Daniyal SM, Hassan IN.   +10 more
europepmc   +1 more source

Pharmacodynamics, pharmacokinetics, interactions with other drugs, toxicity and clinical effectiveness of proton pump inhibitors. [PDF]

Front Pharmacol
Wołowiec Ł, Osiak-Gwiazdowska J, Jaśniak A, Janiak M, Wydeheft L, Łukasiak M, Pellowska M, Grześk G.   +7 more
europepmc   +1 more source

In vitro susceptibility testing of Trichomonas gallinae strains to proton pump inhibitors and nitroimidazoles. [PDF]

Sci Rep
Kerek Á, Csiki BB, Szabó Á, Farkas M, Pitó A, Jerzsele Á, Mag P.   +6 more
europepmc   +1 more source

Advances in Gastroesophageal Reflux Disease Management: Exploring the Role of Potassium-Competitive Acid Blockers and Novel Therapies. [PDF]

Pharmaceuticals (Basel)
Hossa K, Małecka-Wojciesko E.
europepmc   +1 more source

Collagenous gastritis, hyperplastic polyp, and intraepithelial duodenal lymphocytosis in a 15-year-old child: An iconographic case report. [PDF]

Medicine (Baltimore)
Sergi C, Patry J, Kehar M.
europepmc   +1 more source

Clinical Trial: Dose-Finding Study of Linaprazan Glurate, A Novel Potassium-Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive Oesophagitis. [PDF]

Aliment Pharmacol Ther
Sharma P, Vaezi M, Unge P, Andersson K, Larsson K, Popadiyn I, Rosenholm M, Rosztóczy A, Yektaei E, Armstrong D.   +9 more
europepmc   +1 more source